Sorin S.p.A. (SRN) - Product Pipeline Analysis by GlobalData

VIEWS: 51 PAGES: 60

More Info
									                                             Sorin S.p.A. (SRN) - Product Pipeline Analysis

     Reference Code: GDME817PD                                                                                                    Publication Date: NOV 2010



     Company Snapshot                                                              Company Overview
     Key Information
                                                                                   Sorin S.p.A. (Sorin) is engaged in the development of medical
      Sorin S.p.A., Key Facts                                                      technologies for cardiac surgery. It also offers innovative therapies for
                                                                                   cardiac rhythm dysfunctions, and interventional cardiology. Sorin
      Web Address                           www.sorin.comengindex.asp
                                                                                   focuses on three main therapeutic areas, including cardiopulmonary
      Turnover           (in       USD 945.90                                      bypass (extracorporeal circulation and autotransfusion systems),
      Million)                                                                     cardiac rhythm management, and heart valve repair and replacement.
                                                                                   Its research and development (R&D) activities are principally into the
      Number of Employees                   3,695                                  development of various product innovation projects in Cardiopulmonary
      Industry                              Pharmaceuticals and Healthcare         business unit. Annually, more than one million patients are treated with
      Source:Primary / Secondary Research                                          its devices in more than 80 countries worldwide.
      GlobalData




     Sorin S.p.A. Pipeline Products

      Sorin S.p.A. Key Pipeline Products by Equipment Type                         Sorin S.p.A. Key Pipeline Products by Therapy Area

     Equipment Type                                               No of Products   Therapy Area                                              No of Products
     Cardiac Rhythm Management                                               15    Cardiac arrhythmia                                                   13
     Cardiovascular Surgery                                                   5    Bradycardia                                                            3
     Prosthetic Heart Valve                                                   4    Mitral valve regurgitation                                             2
     Remote Patient Monitoring                                                2    Valve dysfunction                                                      2
     Cardiovascular Prosthetic Devices                                        2    Aortic valve disease                                                   1
     Cardiovascular Monitoring and Diagnostic                                 1    Cardiovascular diseases                                                1
     Devices
                                                                                   Tachycardia                                                            1
                                                                                   Source: Primary / Secondary Research
     Source: Primary / Secondary Research
                                                                                   GlobalData
     GlobalData


     Sorin S.p.A. Key Pipeline Products by Equipment Type




      Source: Primary / Secondary Research
      GlobalData




      Sorin S.p.A. Key Pipeline Products by Development Stage                      Sorin S.p.A. Key Pipeline Products by Trial Phase

     Developmental Stage                                          No of Products   Trial Phase                                               No of Products
     Clinicals                                                               22    Phase IV                                              -
     Pre-Clinicals                                                                 Phase III                                                              4
                                                                  -
     Early development                                                        6    Phase II                                                               3
     No Specific Phase                                                        2    Phase I                                               -
     Source: Primary / Secondary Research                                          Source: Primary / Secondary Research
     GlobalData                                                                    GlobalData
     Note : (-) indicates 'Not Available'                                          Note : (-) indicates 'Not Available'



Sorin S.p.A. (SRN) - Product Pipeline Analysis                                                                                         Reference Code: GDME817PD

Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 5
     List of Figures......................................................................................................................................................................................................................................................................... 7
     Sorin S.p.A. - Business Description ....................................................................................................................................................................................................................................... 8
     Key Facts ............................................................................................................................................................................................................................................................................... 9
     Sorin S.p.A. - Major Products and Services......................................................................................................................................................................................................................... 10
           Sorin S.p.A. Pipeline Products by Equipment Type ...................................................................................................................................................................................................... 11
           Sorin S.p.A. Pipeline Products by Development Stage ................................................................................................................................................................................................. 14
           Sorin S.p.A. Pipeline Products by Therapy Area ........................................................................................................................................................................................................... 16
           Sorin S.p.A. Pipeline Products by Trial Phase............................................................................................................................................................................................................... 18
           Sorin S.p.A. Pipeline Products by Milestone Summary ................................................................................................................................................................................................. 20
           3rd Generation Bicarbon Heart Valve............................................................................................................................................................................................................................ 22
                 Product Status......................................................................................................................................................................................................................................................... 22
                 Product Description ................................................................................................................................................................................................................................................. 22
           Beflex Brady Lead ......................................................................................................................................................................................................................................................... 22
                 Product Status......................................................................................................................................................................................................................................................... 22
                 Product Description ................................................................................................................................................................................................................................................. 22
                 Beflex Brady Lead Clinical Trial .............................................................................................................................................................................................................................. 23
           C5 HLM.......................................................................................................................................................................................................................................................................... 23
                 Product Status......................................................................................................................................................................................................................................................... 23
                 Product Description ................................................................................................................................................................................................................................................. 23
                 Product Milestone ................................................................................................................................................................................................................................................... 24
           FREEDOM SOLO.......................................................................................................................................................................................................................................................... 24
                 Product Status......................................................................................................................................................................................................................................................... 24
                 Product Description ................................................................................................................................................................................................................................................. 24
                 Product Milestone ................................................................................................................................................................................................................................................... 25
                 FREEDOM SOLO Clinical Trial............................................................................................................................................................................................................................... 25
           HLM Accessories........................................................................................................................................................................................................................................................... 27
                 Product Status......................................................................................................................................................................................................................................................... 27
                 Product Description ................................................................................................................................................................................................................................................. 27
           LinOx oxygenator........................................................................................................................................................................................................................................................... 28
                 Product Status......................................................................................................................................................................................................................................................... 28
                 Product Description ................................................................................................................................................................................................................................................. 28
           MEMO 3D Semirigid Annuloplasty Ring ........................................................................................................................................................................................................................ 28
                 Product Status......................................................................................................................................................................................................................................................... 28
                 Product Description ................................................................................................................................................................................................................................................. 28
                 Product Milestone ................................................................................................................................................................................................................................................... 29
                 MEMO 3D Semirigid Annuloplasty Ring Clinical Trial............................................................................................................................................................................................. 29
           Mitroflow Aortic Pericardial Heart Valve ........................................................................................................................................................................................................................ 30
                 Product Status......................................................................................................................................................................................................................................................... 30
                 Product Description ................................................................................................................................................................................................................................................. 30
                 Product Milestone ................................................................................................................................................................................................................................................... 30
                 Mitroflow Aortic Pericardial Heart Valve Clinical Trial ............................................................................................................................................................................................. 30
           MRI Brady Lead............................................................................................................................................................................................................................................................. 32
                 Product Status......................................................................................................................................................................................................................................................... 32
                 Product Description ................................................................................................................................................................................................................................................. 32
           New Annuloplasty Ring Model-Sovering ....................................................................................................................................................................................................................... 32
                 Product Status......................................................................................................................................................................................................................................................... 32
                 Product Description ................................................................................................................................................................................................................................................. 32
                 Product Patent Details ............................................................................................................................................................................................................................................ 33
           New gen SonR Lead...................................................................................................................................................................................................................................................... 33
                 Product Status......................................................................................................................................................................................................................................................... 33
                 Product Description ................................................................................................................................................................................................................................................. 33
           New Oxy Apex HP Oxygenator ..................................................................................................................................................................................................................................... 33
                 Product Status......................................................................................................................................................................................................................................................... 33
                 Product Description ................................................................................................................................................................................................................................................. 34
                 Product Patent Details ............................................................................................................................................................................................................................................ 34
           PARADYM 8770 SonR .................................................................................................................................................................................................................................................. 34
                 Product Status......................................................................................................................................................................................................................................................... 34
                 Product Description ................................................................................................................................................................................................................................................. 34

Sorin S.p.A. (SRN) - Product Pipeline Analysis                                                                                                                                                                                                           Reference Code: GDME817PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                                     Page 2
                 Product Milestone ................................................................................................................................................................................................................................................... 35
                 PARADYM 8770 SonR Clinical Trial....................................................................................................................................................................................................................... 35
                 Product Patent Details ............................................................................................................................................................................................................................................ 36
           Paradym CRT-D 8750 ................................................................................................................................................................................................................................................... 36
                 Product Status......................................................................................................................................................................................................................................................... 36
                 Product Description ................................................................................................................................................................................................................................................. 36
                 Product Milestone ................................................................................................................................................................................................................................................... 37
                 Paradym CRT-D 8750 Clinical Trial ........................................................................................................................................................................................................................ 37
                 Product Patent Details ............................................................................................................................................................................................................................................ 38
           Paradym DR .................................................................................................................................................................................................................................................................. 39
                 Product Status......................................................................................................................................................................................................................................................... 39
                 Product Description ................................................................................................................................................................................................................................................. 39
           Paradym RF Platform .................................................................................................................................................................................................................................................... 39
                 Product Status......................................................................................................................................................................................................................................................... 39
                 Product Description ................................................................................................................................................................................................................................................. 39
                 Paradym RF Platform Clinical Trial ......................................................................................................................................................................................................................... 40
           Paradym VR Model 8250............................................................................................................................................................................................................................................... 41
                 Product Status......................................................................................................................................................................................................................................................... 41
                 Product Description ................................................................................................................................................................................................................................................. 41
           Perceval S Aortic Heart Valve ....................................................................................................................................................................................................................................... 41
                 Product Status......................................................................................................................................................................................................................................................... 41
                 Product Description ................................................................................................................................................................................................................................................. 41
                 Product Milestone ................................................................................................................................................................................................................................................... 42
                 Perceval S Aortic Heart Valve Clinical Trial ............................................................................................................................................................................................................ 42
                 Product Patent Details ............................................................................................................................................................................................................................................ 44
           Platinium ICD – CRT-D.................................................................................................................................................................................................................................................. 45
                 Product Status......................................................................................................................................................................................................................................................... 45
                 Product Description ................................................................................................................................................................................................................................................. 45
           Remote Monitoring Solution .......................................................................................................................................................................................................................................... 45
                 Product Status......................................................................................................................................................................................................................................................... 45
                 Product Description ................................................................................................................................................................................................................................................. 45
                 Product Milestone ................................................................................................................................................................................................................................................... 45
           Remote Monitoring Solution V2 ..................................................................................................................................................................................................................................... 46
                 Product Status......................................................................................................................................................................................................................................................... 46
                 Product Description ................................................................................................................................................................................................................................................. 46
           Reply MRI Pacemaker................................................................................................................................................................................................................................................... 46
                 Product Status......................................................................................................................................................................................................................................................... 46
                 Product Description ................................................................................................................................................................................................................................................. 47
           Situs2 LV Bipolar Lead .................................................................................................................................................................................................................................................. 47
                 Product Status......................................................................................................................................................................................................................................................... 47
                 Product Description ................................................................................................................................................................................................................................................. 47
           SonRFix Lead ................................................................................................................................................................................................................................................................ 47
                 Product Status......................................................................................................................................................................................................................................................... 47
                 Product Description ................................................................................................................................................................................................................................................. 47
                 SonRFix Lead Clinical Trial..................................................................................................................................................................................................................................... 48
           Spiderflash AFIB............................................................................................................................................................................................................................................................ 48
                 Product Status......................................................................................................................................................................................................................................................... 48
                 Product Description ..............................................................................................................................................................
								
To top